nodes	percent_of_prediction	percent_of_DWPC	metapath
Tacrolimus—ALB—coronary artery disease	0.0846	1	CbGaD
Tacrolimus—ORM1—Penbutolol—coronary artery disease	0.0452	0.0819	CbGbCtD
Tacrolimus—ORM1—Pitavastatin—coronary artery disease	0.0395	0.0716	CbGbCtD
Tacrolimus—CYP3A7—Eplerenone—coronary artery disease	0.0189	0.0343	CbGbCtD
Tacrolimus—CYP3A7-CYP3A51P—Eplerenone—coronary artery disease	0.0189	0.0343	CbGbCtD
Tacrolimus—ALB—Pitavastatin—coronary artery disease	0.0166	0.0301	CbGbCtD
Tacrolimus—ALB—Valsartan—coronary artery disease	0.0162	0.0293	CbGbCtD
Tacrolimus—ABCB1—Ticagrelor—coronary artery disease	0.0161	0.0292	CbGbCtD
Tacrolimus—CYP3A5—Clopidogrel—coronary artery disease	0.0153	0.0277	CbGbCtD
Tacrolimus—CYP3A5—Eplerenone—coronary artery disease	0.0142	0.0258	CbGbCtD
Tacrolimus—ALB—Rosuvastatin—coronary artery disease	0.0122	0.0222	CbGbCtD
Tacrolimus—CYP3A7-CYP3A51P—Simvastatin—coronary artery disease	0.0122	0.0221	CbGbCtD
Tacrolimus—CYP3A7—Simvastatin—coronary artery disease	0.0122	0.0221	CbGbCtD
Tacrolimus—CYP3A7—Lovastatin—coronary artery disease	0.0119	0.0217	CbGbCtD
Tacrolimus—CYP3A7-CYP3A51P—Lovastatin—coronary artery disease	0.0119	0.0217	CbGbCtD
Tacrolimus—ALB—Acetylsalicylic acid—coronary artery disease	0.0119	0.0216	CbGbCtD
Tacrolimus—ALB—Captopril—coronary artery disease	0.0118	0.0214	CbGbCtD
Tacrolimus—CYP3A7—Atorvastatin—coronary artery disease	0.0109	0.0197	CbGbCtD
Tacrolimus—CYP3A7-CYP3A51P—Atorvastatin—coronary artery disease	0.0109	0.0197	CbGbCtD
Tacrolimus—ABCB1—Perindopril—coronary artery disease	0.00994	0.018	CbGbCtD
Tacrolimus—ABCB1—Clopidogrel—coronary artery disease	0.00994	0.018	CbGbCtD
Tacrolimus—CYP3A5—Rosuvastatin—coronary artery disease	0.00984	0.0179	CbGbCtD
Tacrolimus—CYP3A4—Ticagrelor—coronary artery disease	0.00964	0.0175	CbGbCtD
Tacrolimus—ALB—Furosemide—coronary artery disease	0.00947	0.0172	CbGbCtD
Tacrolimus—ALB—Losartan—coronary artery disease	0.00928	0.0168	CbGbCtD
Tacrolimus—CYP3A5—Simvastatin—coronary artery disease	0.00915	0.0166	CbGbCtD
Tacrolimus—CYP3A5—Lovastatin—coronary artery disease	0.00896	0.0162	CbGbCtD
Tacrolimus—CYP3A5—Pravastatin—coronary artery disease	0.00896	0.0162	CbGbCtD
Tacrolimus—ABCB1—Pitavastatin—coronary artery disease	0.00869	0.0158	CbGbCtD
Tacrolimus—ABCB1—Telmisartan—coronary artery disease	0.00869	0.0158	CbGbCtD
Tacrolimus—CYP3A4—Fenofibrate—coronary artery disease	0.00859	0.0156	CbGbCtD
Tacrolimus—ABCB1—Enalapril—coronary artery disease	0.00824	0.0149	CbGbCtD
Tacrolimus—ABCB1—Lisinopril—coronary artery disease	0.00824	0.0149	CbGbCtD
Tacrolimus—CYP3A5—Atorvastatin—coronary artery disease	0.00816	0.0148	CbGbCtD
Tacrolimus—CYP3A5—Losartan—coronary artery disease	0.00746	0.0135	CbGbCtD
Tacrolimus—ABCB1—Timolol—coronary artery disease	0.007	0.0127	CbGbCtD
Tacrolimus—CYP3A4—Gemfibrozil—coronary artery disease	0.00687	0.0125	CbGbCtD
Tacrolimus—ABCB1—Ezetimibe—coronary artery disease	0.00641	0.0116	CbGbCtD
Tacrolimus—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00624	0.0113	CbGbCtD
Tacrolimus—ABCB1—Captopril—coronary artery disease	0.00617	0.0112	CbGbCtD
Tacrolimus—CYP3A4—Clopidogrel—coronary artery disease	0.00596	0.0108	CbGbCtD
Tacrolimus—ABCB1—Simvastatin—coronary artery disease	0.00596	0.0108	CbGbCtD
Tacrolimus—ABCB1—Pravastatin—coronary artery disease	0.00583	0.0106	CbGbCtD
Tacrolimus—ABCB1—Lovastatin—coronary artery disease	0.00583	0.0106	CbGbCtD
Tacrolimus—CYP3A4—Eplerenone—coronary artery disease	0.00554	0.01	CbGbCtD
Tacrolimus—ABCB1—Atorvastatin—coronary artery disease	0.00531	0.00963	CbGbCtD
Tacrolimus—CYP3A4—Enalapril—coronary artery disease	0.00494	0.00895	CbGbCtD
Tacrolimus—ABCB1—Losartan—coronary artery disease	0.00486	0.00881	CbGbCtD
Tacrolimus—CYP3A4—Rosuvastatin—coronary artery disease	0.00384	0.00696	CbGbCtD
Tacrolimus—CYP3A4—Ezetimibe—coronary artery disease	0.00384	0.00696	CbGbCtD
Tacrolimus—CYP3A4—Simvastatin—coronary artery disease	0.00357	0.00647	CbGbCtD
Tacrolimus—CYP3A4—Pravastatin—coronary artery disease	0.00349	0.00633	CbGbCtD
Tacrolimus—CYP3A4—Lovastatin—coronary artery disease	0.00349	0.00633	CbGbCtD
Tacrolimus—CYP3A4—Atorvastatin—coronary artery disease	0.00318	0.00577	CbGbCtD
Tacrolimus—CYP3A4—Losartan—coronary artery disease	0.00291	0.00528	CbGbCtD
Tacrolimus—ABCA5—cardiac ventricle—coronary artery disease	0.00252	0.0995	CbGeAlD
Tacrolimus—ABCA5—myocardium—coronary artery disease	0.00237	0.0936	CbGeAlD
Tacrolimus—PPP3CA—cardiac ventricle—coronary artery disease	0.0017	0.0672	CbGeAlD
Tacrolimus—ABCA5—heart—coronary artery disease	0.00166	0.0653	CbGeAlD
Tacrolimus—PPP3CA—myocardium—coronary artery disease	0.0016	0.0632	CbGeAlD
Tacrolimus—Sirolimus—FGF2—coronary artery disease	0.00155	1	CrCbGaD
Tacrolimus—ABCA5—cardiac atrium—coronary artery disease	0.00142	0.0559	CbGeAlD
Tacrolimus—ABCA5—blood—coronary artery disease	0.00124	0.0487	CbGeAlD
Tacrolimus—FKBP1A—cardiac ventricle—coronary artery disease	0.00113	0.0446	CbGeAlD
Tacrolimus—PPP3CA—heart—coronary artery disease	0.00112	0.0441	CbGeAlD
Tacrolimus—FKBP1A—myocardium—coronary artery disease	0.00106	0.042	CbGeAlD
Tacrolimus—PPP3CA—cardiovascular system—coronary artery disease	0.00106	0.0416	CbGeAlD
Tacrolimus—PPP3CA—cardiac atrium—coronary artery disease	0.000957	0.0377	CbGeAlD
Tacrolimus—PPP3CA—blood—coronary artery disease	0.000835	0.0329	CbGeAlD
Tacrolimus—MTOR—heart—coronary artery disease	0.000826	0.0326	CbGeAlD
Tacrolimus—MTOR—cardiovascular system—coronary artery disease	0.00078	0.0308	CbGeAlD
Tacrolimus—FKBP1A—heart—coronary artery disease	0.000743	0.0293	CbGeAlD
Tacrolimus—FKBP1A—cardiovascular system—coronary artery disease	0.000701	0.0277	CbGeAlD
Tacrolimus—FKBP1A—cardiac atrium—coronary artery disease	0.000636	0.0251	CbGeAlD
Tacrolimus—MTOR—blood—coronary artery disease	0.000617	0.0243	CbGeAlD
Tacrolimus—FKBP1A—blood—coronary artery disease	0.000555	0.0219	CbGeAlD
Tacrolimus—ALB—heart—coronary artery disease	0.00051	0.0201	CbGeAlD
Tacrolimus—ORM1—blood—coronary artery disease	0.000434	0.0171	CbGeAlD
Tacrolimus—CYP3A5—blood—coronary artery disease	0.000241	0.00952	CbGeAlD
Tacrolimus—CYP3A4—blood—coronary artery disease	0.000181	0.00715	CbGeAlD
Tacrolimus—ABCB1—heart—coronary artery disease	0.000172	0.00678	CbGeAlD
Tacrolimus—ABCB1—cardiovascular system—coronary artery disease	0.000162	0.0064	CbGeAlD
Tacrolimus—ABCB1—blood—coronary artery disease	0.000128	0.00506	CbGeAlD
Tacrolimus—Malaise—Lisinopril—coronary artery disease	2.9e-05	0.000138	CcSEcCtD
Tacrolimus—Oedema—Ramipril—coronary artery disease	2.89e-05	0.000137	CcSEcCtD
Tacrolimus—Anaphylactic shock—Ramipril—coronary artery disease	2.89e-05	0.000137	CcSEcCtD
Tacrolimus—Vertigo—Lisinopril—coronary artery disease	2.89e-05	0.000137	CcSEcCtD
Tacrolimus—Dry mouth—Timolol—coronary artery disease	2.89e-05	0.000137	CcSEcCtD
Tacrolimus—Pain—Losartan—coronary artery disease	2.88e-05	0.000137	CcSEcCtD
Tacrolimus—Constipation—Losartan—coronary artery disease	2.88e-05	0.000137	CcSEcCtD
Tacrolimus—Syncope—Lisinopril—coronary artery disease	2.88e-05	0.000137	CcSEcCtD
Tacrolimus—Vomiting—Eplerenone—coronary artery disease	2.88e-05	0.000137	CcSEcCtD
Tacrolimus—Feeling abnormal—Furosemide—coronary artery disease	2.88e-05	0.000137	CcSEcCtD
Tacrolimus—Leukopenia—Lisinopril—coronary artery disease	2.88e-05	0.000137	CcSEcCtD
Tacrolimus—Nausea—Fenofibrate—coronary artery disease	2.87e-05	0.000136	CcSEcCtD
Tacrolimus—Pruritus—Niacin—coronary artery disease	2.87e-05	0.000136	CcSEcCtD
Tacrolimus—Asthenia—Pravastatin—coronary artery disease	2.87e-05	0.000136	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Furosemide—coronary artery disease	2.86e-05	0.000136	CcSEcCtD
Tacrolimus—Rash—Eplerenone—coronary artery disease	2.86e-05	0.000136	CcSEcCtD
Tacrolimus—Urticaria—Perindopril—coronary artery disease	2.86e-05	0.000136	CcSEcCtD
Tacrolimus—Hypersensitivity—Trandolapril—coronary artery disease	2.86e-05	0.000136	CcSEcCtD
Tacrolimus—Dermatitis—Eplerenone—coronary artery disease	2.86e-05	0.000136	CcSEcCtD
Tacrolimus—Diarrhoea—Valsartan—coronary artery disease	2.85e-05	0.000135	CcSEcCtD
Tacrolimus—Confusional state—Timolol—coronary artery disease	2.85e-05	0.000135	CcSEcCtD
Tacrolimus—Shock—Ramipril—coronary artery disease	2.85e-05	0.000135	CcSEcCtD
Tacrolimus—Hypersensitivity—Enalapril—coronary artery disease	2.85e-05	0.000135	CcSEcCtD
Tacrolimus—Body temperature increased—Perindopril—coronary artery disease	2.84e-05	0.000135	CcSEcCtD
Tacrolimus—Abdominal pain—Perindopril—coronary artery disease	2.84e-05	0.000135	CcSEcCtD
Tacrolimus—Palpitations—Lisinopril—coronary artery disease	2.84e-05	0.000135	CcSEcCtD
Tacrolimus—Diarrhoea—Olmesartan—coronary artery disease	2.84e-05	0.000135	CcSEcCtD
Tacrolimus—Headache—Eplerenone—coronary artery disease	2.84e-05	0.000135	CcSEcCtD
Tacrolimus—Nervous system disorder—Ramipril—coronary artery disease	2.84e-05	0.000135	CcSEcCtD
Tacrolimus—Thrombocytopenia—Ramipril—coronary artery disease	2.83e-05	0.000134	CcSEcCtD
Tacrolimus—Anaphylactic shock—Timolol—coronary artery disease	2.83e-05	0.000134	CcSEcCtD
Tacrolimus—Oedema—Timolol—coronary artery disease	2.83e-05	0.000134	CcSEcCtD
Tacrolimus—Pruritus—Pravastatin—coronary artery disease	2.83e-05	0.000134	CcSEcCtD
Tacrolimus—Loss of consciousness—Lisinopril—coronary artery disease	2.83e-05	0.000134	CcSEcCtD
Tacrolimus—Nausea—Clopidogrel—coronary artery disease	2.82e-05	0.000134	CcSEcCtD
Tacrolimus—Tachycardia—Ramipril—coronary artery disease	2.82e-05	0.000134	CcSEcCtD
Tacrolimus—Skin disorder—Ramipril—coronary artery disease	2.81e-05	0.000133	CcSEcCtD
Tacrolimus—Infection—Timolol—coronary artery disease	2.81e-05	0.000133	CcSEcCtD
Tacrolimus—Vomiting—Simvastatin—coronary artery disease	2.81e-05	0.000133	CcSEcCtD
Tacrolimus—Hypersensitivity—Telmisartan—coronary artery disease	2.81e-05	0.000133	CcSEcCtD
Tacrolimus—Cough—Lisinopril—coronary artery disease	2.81e-05	0.000133	CcSEcCtD
Tacrolimus—Nausea—Lovastatin—coronary artery disease	2.8e-05	0.000133	CcSEcCtD
Tacrolimus—Hyperhidrosis—Ramipril—coronary artery disease	2.8e-05	0.000133	CcSEcCtD
Tacrolimus—Rash—Simvastatin—coronary artery disease	2.79e-05	0.000132	CcSEcCtD
Tacrolimus—Dermatitis—Simvastatin—coronary artery disease	2.78e-05	0.000132	CcSEcCtD
Tacrolimus—Asthenia—Trandolapril—coronary artery disease	2.78e-05	0.000132	CcSEcCtD
Tacrolimus—Shock—Timolol—coronary artery disease	2.78e-05	0.000132	CcSEcCtD
Tacrolimus—Feeling abnormal—Losartan—coronary artery disease	2.78e-05	0.000132	CcSEcCtD
Tacrolimus—Urticaria—Furosemide—coronary artery disease	2.78e-05	0.000132	CcSEcCtD
Tacrolimus—Diarrhoea—Niacin—coronary artery disease	2.78e-05	0.000132	CcSEcCtD
Tacrolimus—Nervous system disorder—Timolol—coronary artery disease	2.77e-05	0.000132	CcSEcCtD
Tacrolimus—Asthenia—Enalapril—coronary artery disease	2.77e-05	0.000132	CcSEcCtD
Tacrolimus—Headache—Simvastatin—coronary artery disease	2.77e-05	0.000131	CcSEcCtD
Tacrolimus—Abdominal pain—Furosemide—coronary artery disease	2.76e-05	0.000131	CcSEcCtD
Tacrolimus—Body temperature increased—Furosemide—coronary artery disease	2.76e-05	0.000131	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Losartan—coronary artery disease	2.76e-05	0.000131	CcSEcCtD
Tacrolimus—Dizziness—Valsartan—coronary artery disease	2.76e-05	0.000131	CcSEcCtD
Tacrolimus—Anorexia—Ramipril—coronary artery disease	2.76e-05	0.000131	CcSEcCtD
Tacrolimus—Nausea—Ezetimibe—coronary artery disease	2.75e-05	0.000131	CcSEcCtD
Tacrolimus—Skin disorder—Timolol—coronary artery disease	2.75e-05	0.00013	CcSEcCtD
Tacrolimus—Dizziness—Olmesartan—coronary artery disease	2.75e-05	0.00013	CcSEcCtD
Tacrolimus—Pruritus—Trandolapril—coronary artery disease	2.74e-05	0.00013	CcSEcCtD
Tacrolimus—Chest pain—Lisinopril—coronary artery disease	2.74e-05	0.00013	CcSEcCtD
Tacrolimus—Arthralgia—Lisinopril—coronary artery disease	2.74e-05	0.00013	CcSEcCtD
Tacrolimus—Myalgia—Lisinopril—coronary artery disease	2.74e-05	0.00013	CcSEcCtD
Tacrolimus—Hyperhidrosis—Timolol—coronary artery disease	2.73e-05	0.00013	CcSEcCtD
Tacrolimus—Asthenia—Telmisartan—coronary artery disease	2.73e-05	0.00013	CcSEcCtD
Tacrolimus—Pruritus—Enalapril—coronary artery disease	2.73e-05	0.00013	CcSEcCtD
Tacrolimus—Diarrhoea—Pravastatin—coronary artery disease	2.73e-05	0.00013	CcSEcCtD
Tacrolimus—Anxiety—Lisinopril—coronary artery disease	2.73e-05	0.000129	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	2.72e-05	0.000129	CcSEcCtD
Tacrolimus—Discomfort—Lisinopril—coronary artery disease	2.7e-05	0.000128	CcSEcCtD
Tacrolimus—Hypotension—Ramipril—coronary artery disease	2.7e-05	0.000128	CcSEcCtD
Tacrolimus—Anorexia—Timolol—coronary artery disease	2.7e-05	0.000128	CcSEcCtD
Tacrolimus—Pruritus—Telmisartan—coronary artery disease	2.7e-05	0.000128	CcSEcCtD
Tacrolimus—Nausea—Eplerenone—coronary artery disease	2.69e-05	0.000128	CcSEcCtD
Tacrolimus—Dizziness—Niacin—coronary artery disease	2.68e-05	0.000127	CcSEcCtD
Tacrolimus—Urticaria—Losartan—coronary artery disease	2.68e-05	0.000127	CcSEcCtD
Tacrolimus—Dry mouth—Lisinopril—coronary artery disease	2.68e-05	0.000127	CcSEcCtD
Tacrolimus—Body temperature increased—Losartan—coronary artery disease	2.67e-05	0.000127	CcSEcCtD
Tacrolimus—Abdominal pain—Losartan—coronary artery disease	2.67e-05	0.000127	CcSEcCtD
Tacrolimus—Asthenia—Captopril—coronary artery disease	2.66e-05	0.000126	CcSEcCtD
Tacrolimus—Diarrhoea—Trandolapril—coronary artery disease	2.65e-05	0.000126	CcSEcCtD
Tacrolimus—Vomiting—Valsartan—coronary artery disease	2.65e-05	0.000126	CcSEcCtD
Tacrolimus—Confusional state—Lisinopril—coronary artery disease	2.65e-05	0.000126	CcSEcCtD
Tacrolimus—Diarrhoea—Enalapril—coronary artery disease	2.64e-05	0.000125	CcSEcCtD
Tacrolimus—Hypotension—Timolol—coronary artery disease	2.64e-05	0.000125	CcSEcCtD
Tacrolimus—Dizziness—Pravastatin—coronary artery disease	2.64e-05	0.000125	CcSEcCtD
Tacrolimus—Vomiting—Olmesartan—coronary artery disease	2.64e-05	0.000125	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Ramipril—coronary artery disease	2.64e-05	0.000125	CcSEcCtD
Tacrolimus—Rash—Valsartan—coronary artery disease	2.63e-05	0.000125	CcSEcCtD
Tacrolimus—Dermatitis—Valsartan—coronary artery disease	2.63e-05	0.000125	CcSEcCtD
Tacrolimus—Nausea—Simvastatin—coronary artery disease	2.62e-05	0.000125	CcSEcCtD
Tacrolimus—Oedema—Lisinopril—coronary artery disease	2.62e-05	0.000125	CcSEcCtD
Tacrolimus—Anaphylactic shock—Lisinopril—coronary artery disease	2.62e-05	0.000125	CcSEcCtD
Tacrolimus—Pruritus—Captopril—coronary artery disease	2.62e-05	0.000124	CcSEcCtD
Tacrolimus—Rash—Olmesartan—coronary artery disease	2.62e-05	0.000124	CcSEcCtD
Tacrolimus—Insomnia—Ramipril—coronary artery disease	2.62e-05	0.000124	CcSEcCtD
Tacrolimus—Dermatitis—Olmesartan—coronary artery disease	2.62e-05	0.000124	CcSEcCtD
Tacrolimus—Headache—Valsartan—coronary artery disease	2.61e-05	0.000124	CcSEcCtD
Tacrolimus—Diarrhoea—Telmisartan—coronary artery disease	2.61e-05	0.000124	CcSEcCtD
Tacrolimus—Infection—Lisinopril—coronary artery disease	2.61e-05	0.000124	CcSEcCtD
Tacrolimus—Headache—Olmesartan—coronary artery disease	2.6e-05	0.000123	CcSEcCtD
Tacrolimus—Paraesthesia—Ramipril—coronary artery disease	2.6e-05	0.000123	CcSEcCtD
Tacrolimus—Shock—Lisinopril—coronary artery disease	2.58e-05	0.000123	CcSEcCtD
Tacrolimus—Asthenia—Perindopril—coronary artery disease	2.58e-05	0.000123	CcSEcCtD
Tacrolimus—Dyspnoea—Ramipril—coronary artery disease	2.58e-05	0.000122	CcSEcCtD
Tacrolimus—Vomiting—Niacin—coronary artery disease	2.58e-05	0.000122	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Timolol—coronary artery disease	2.58e-05	0.000122	CcSEcCtD
Tacrolimus—Hypersensitivity—Furosemide—coronary artery disease	2.58e-05	0.000122	CcSEcCtD
Tacrolimus—Somnolence—Ramipril—coronary artery disease	2.57e-05	0.000122	CcSEcCtD
Tacrolimus—Thrombocytopenia—Lisinopril—coronary artery disease	2.57e-05	0.000122	CcSEcCtD
Tacrolimus—Dizziness—Trandolapril—coronary artery disease	2.56e-05	0.000122	CcSEcCtD
Tacrolimus—Tachycardia—Lisinopril—coronary artery disease	2.56e-05	0.000122	CcSEcCtD
Tacrolimus—Insomnia—Timolol—coronary artery disease	2.56e-05	0.000121	CcSEcCtD
Tacrolimus—Rash—Niacin—coronary artery disease	2.56e-05	0.000121	CcSEcCtD
Tacrolimus—Dermatitis—Niacin—coronary artery disease	2.55e-05	0.000121	CcSEcCtD
Tacrolimus—Dizziness—Enalapril—coronary artery disease	2.55e-05	0.000121	CcSEcCtD
Tacrolimus—Skin disorder—Lisinopril—coronary artery disease	2.55e-05	0.000121	CcSEcCtD
Tacrolimus—Dyspepsia—Ramipril—coronary artery disease	2.55e-05	0.000121	CcSEcCtD
Tacrolimus—Pruritus—Perindopril—coronary artery disease	2.54e-05	0.000121	CcSEcCtD
Tacrolimus—Headache—Niacin—coronary artery disease	2.54e-05	0.000121	CcSEcCtD
Tacrolimus—Paraesthesia—Timolol—coronary artery disease	2.54e-05	0.000121	CcSEcCtD
Tacrolimus—Vomiting—Pravastatin—coronary artery disease	2.54e-05	0.000121	CcSEcCtD
Tacrolimus—Hyperhidrosis—Lisinopril—coronary artery disease	2.54e-05	0.00012	CcSEcCtD
Tacrolimus—Diarrhoea—Captopril—coronary artery disease	2.53e-05	0.00012	CcSEcCtD
Tacrolimus—Dyspnoea—Timolol—coronary artery disease	2.52e-05	0.00012	CcSEcCtD
Tacrolimus—Dizziness—Telmisartan—coronary artery disease	2.52e-05	0.00012	CcSEcCtD
Tacrolimus—Rash—Pravastatin—coronary artery disease	2.52e-05	0.00012	CcSEcCtD
Tacrolimus—Dermatitis—Pravastatin—coronary artery disease	2.52e-05	0.000119	CcSEcCtD
Tacrolimus—Decreased appetite—Ramipril—coronary artery disease	2.51e-05	0.000119	CcSEcCtD
Tacrolimus—Somnolence—Timolol—coronary artery disease	2.51e-05	0.000119	CcSEcCtD
Tacrolimus—Asthenia—Furosemide—coronary artery disease	2.51e-05	0.000119	CcSEcCtD
Tacrolimus—Headache—Pravastatin—coronary artery disease	2.5e-05	0.000119	CcSEcCtD
Tacrolimus—Anorexia—Lisinopril—coronary artery disease	2.5e-05	0.000119	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Ramipril—coronary artery disease	2.5e-05	0.000119	CcSEcCtD
Tacrolimus—Fatigue—Ramipril—coronary artery disease	2.49e-05	0.000118	CcSEcCtD
Tacrolimus—Dyspepsia—Timolol—coronary artery disease	2.49e-05	0.000118	CcSEcCtD
Tacrolimus—Hypersensitivity—Losartan—coronary artery disease	2.49e-05	0.000118	CcSEcCtD
Tacrolimus—Nausea—Valsartan—coronary artery disease	2.48e-05	0.000118	CcSEcCtD
Tacrolimus—Pruritus—Furosemide—coronary artery disease	2.47e-05	0.000117	CcSEcCtD
Tacrolimus—Constipation—Ramipril—coronary artery disease	2.47e-05	0.000117	CcSEcCtD
Tacrolimus—Nausea—Olmesartan—coronary artery disease	2.47e-05	0.000117	CcSEcCtD
Tacrolimus—Vomiting—Trandolapril—coronary artery disease	2.47e-05	0.000117	CcSEcCtD
Tacrolimus—Diarrhoea—Perindopril—coronary artery disease	2.46e-05	0.000117	CcSEcCtD
Tacrolimus—Decreased appetite—Timolol—coronary artery disease	2.46e-05	0.000117	CcSEcCtD
Tacrolimus—Vomiting—Enalapril—coronary artery disease	2.46e-05	0.000117	CcSEcCtD
Tacrolimus—Hypotension—Lisinopril—coronary artery disease	2.45e-05	0.000116	CcSEcCtD
Tacrolimus—Dizziness—Captopril—coronary artery disease	2.45e-05	0.000116	CcSEcCtD
Tacrolimus—Rash—Trandolapril—coronary artery disease	2.45e-05	0.000116	CcSEcCtD
Tacrolimus—Dermatitis—Trandolapril—coronary artery disease	2.44e-05	0.000116	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Timolol—coronary artery disease	2.44e-05	0.000116	CcSEcCtD
Tacrolimus—Fatigue—Timolol—coronary artery disease	2.44e-05	0.000116	CcSEcCtD
Tacrolimus—Rash—Enalapril—coronary artery disease	2.44e-05	0.000116	CcSEcCtD
Tacrolimus—Dermatitis—Enalapril—coronary artery disease	2.43e-05	0.000116	CcSEcCtD
Tacrolimus—Headache—Trandolapril—coronary artery disease	2.43e-05	0.000115	CcSEcCtD
Tacrolimus—Vomiting—Telmisartan—coronary artery disease	2.42e-05	0.000115	CcSEcCtD
Tacrolimus—Asthenia—Losartan—coronary artery disease	2.42e-05	0.000115	CcSEcCtD
Tacrolimus—Headache—Enalapril—coronary artery disease	2.42e-05	0.000115	CcSEcCtD
Tacrolimus—Pain—Timolol—coronary artery disease	2.42e-05	0.000115	CcSEcCtD
Tacrolimus—Nausea—Niacin—coronary artery disease	2.41e-05	0.000114	CcSEcCtD
Tacrolimus—Rash—Telmisartan—coronary artery disease	2.4e-05	0.000114	CcSEcCtD
Tacrolimus—Dermatitis—Telmisartan—coronary artery disease	2.4e-05	0.000114	CcSEcCtD
Tacrolimus—Diarrhoea—Furosemide—coronary artery disease	2.39e-05	0.000114	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Lisinopril—coronary artery disease	2.39e-05	0.000113	CcSEcCtD
Tacrolimus—Pruritus—Losartan—coronary artery disease	2.39e-05	0.000113	CcSEcCtD
Tacrolimus—Headache—Telmisartan—coronary artery disease	2.39e-05	0.000113	CcSEcCtD
Tacrolimus—Feeling abnormal—Ramipril—coronary artery disease	2.38e-05	0.000113	CcSEcCtD
Tacrolimus—Dizziness—Perindopril—coronary artery disease	2.38e-05	0.000113	CcSEcCtD
Tacrolimus—Insomnia—Lisinopril—coronary artery disease	2.37e-05	0.000113	CcSEcCtD
Tacrolimus—Nausea—Pravastatin—coronary artery disease	2.37e-05	0.000113	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Ramipril—coronary artery disease	2.37e-05	0.000112	CcSEcCtD
Tacrolimus—Paraesthesia—Lisinopril—coronary artery disease	2.36e-05	0.000112	CcSEcCtD
Tacrolimus—Vomiting—Captopril—coronary artery disease	2.36e-05	0.000112	CcSEcCtD
Tacrolimus—Dyspnoea—Lisinopril—coronary artery disease	2.34e-05	0.000111	CcSEcCtD
Tacrolimus—Rash—Captopril—coronary artery disease	2.34e-05	0.000111	CcSEcCtD
Tacrolimus—Dermatitis—Captopril—coronary artery disease	2.33e-05	0.000111	CcSEcCtD
Tacrolimus—Somnolence—Lisinopril—coronary artery disease	2.33e-05	0.000111	CcSEcCtD
Tacrolimus—Feeling abnormal—Timolol—coronary artery disease	2.33e-05	0.000111	CcSEcCtD
Tacrolimus—Headache—Captopril—coronary artery disease	2.32e-05	0.00011	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Timolol—coronary artery disease	2.31e-05	0.00011	CcSEcCtD
Tacrolimus—Dizziness—Furosemide—coronary artery disease	2.31e-05	0.00011	CcSEcCtD
Tacrolimus—Dyspepsia—Lisinopril—coronary artery disease	2.31e-05	0.00011	CcSEcCtD
Tacrolimus—Diarrhoea—Losartan—coronary artery disease	2.31e-05	0.00011	CcSEcCtD
Tacrolimus—Nausea—Trandolapril—coronary artery disease	2.3e-05	0.000109	CcSEcCtD
Tacrolimus—Urticaria—Ramipril—coronary artery disease	2.3e-05	0.000109	CcSEcCtD
Tacrolimus—Nausea—Enalapril—coronary artery disease	2.29e-05	0.000109	CcSEcCtD
Tacrolimus—Vomiting—Perindopril—coronary artery disease	2.29e-05	0.000109	CcSEcCtD
Tacrolimus—Body temperature increased—Ramipril—coronary artery disease	2.29e-05	0.000109	CcSEcCtD
Tacrolimus—Abdominal pain—Ramipril—coronary artery disease	2.29e-05	0.000109	CcSEcCtD
Tacrolimus—Decreased appetite—Lisinopril—coronary artery disease	2.28e-05	0.000108	CcSEcCtD
Tacrolimus—Rash—Perindopril—coronary artery disease	2.27e-05	0.000108	CcSEcCtD
Tacrolimus—Dermatitis—Perindopril—coronary artery disease	2.27e-05	0.000108	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Lisinopril—coronary artery disease	2.26e-05	0.000108	CcSEcCtD
Tacrolimus—Nausea—Telmisartan—coronary artery disease	2.26e-05	0.000107	CcSEcCtD
Tacrolimus—Fatigue—Lisinopril—coronary artery disease	2.26e-05	0.000107	CcSEcCtD
Tacrolimus—Headache—Perindopril—coronary artery disease	2.25e-05	0.000107	CcSEcCtD
Tacrolimus—Urticaria—Timolol—coronary artery disease	2.25e-05	0.000107	CcSEcCtD
Tacrolimus—Pain—Lisinopril—coronary artery disease	2.24e-05	0.000107	CcSEcCtD
Tacrolimus—Constipation—Lisinopril—coronary artery disease	2.24e-05	0.000107	CcSEcCtD
Tacrolimus—Abdominal pain—Timolol—coronary artery disease	2.24e-05	0.000106	CcSEcCtD
Tacrolimus—Body temperature increased—Timolol—coronary artery disease	2.24e-05	0.000106	CcSEcCtD
Tacrolimus—Dizziness—Losartan—coronary artery disease	2.23e-05	0.000106	CcSEcCtD
Tacrolimus—Vomiting—Furosemide—coronary artery disease	2.22e-05	0.000106	CcSEcCtD
Tacrolimus—Rash—Furosemide—coronary artery disease	2.2e-05	0.000105	CcSEcCtD
Tacrolimus—Dermatitis—Furosemide—coronary artery disease	2.2e-05	0.000105	CcSEcCtD
Tacrolimus—Nausea—Captopril—coronary artery disease	2.2e-05	0.000104	CcSEcCtD
Tacrolimus—Headache—Furosemide—coronary artery disease	2.19e-05	0.000104	CcSEcCtD
Tacrolimus—Feeling abnormal—Lisinopril—coronary artery disease	2.16e-05	0.000103	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Lisinopril—coronary artery disease	2.15e-05	0.000102	CcSEcCtD
Tacrolimus—Vomiting—Losartan—coronary artery disease	2.14e-05	0.000102	CcSEcCtD
Tacrolimus—Nausea—Perindopril—coronary artery disease	2.14e-05	0.000101	CcSEcCtD
Tacrolimus—Hypersensitivity—Ramipril—coronary artery disease	2.13e-05	0.000101	CcSEcCtD
Tacrolimus—Rash—Losartan—coronary artery disease	2.13e-05	0.000101	CcSEcCtD
Tacrolimus—Dermatitis—Losartan—coronary artery disease	2.13e-05	0.000101	CcSEcCtD
Tacrolimus—Headache—Losartan—coronary artery disease	2.11e-05	0.0001	CcSEcCtD
Tacrolimus—Urticaria—Lisinopril—coronary artery disease	2.08e-05	9.89e-05	CcSEcCtD
Tacrolimus—Hypersensitivity—Timolol—coronary artery disease	2.08e-05	9.89e-05	CcSEcCtD
Tacrolimus—Nausea—Furosemide—coronary artery disease	2.08e-05	9.86e-05	CcSEcCtD
Tacrolimus—Asthenia—Ramipril—coronary artery disease	2.08e-05	9.85e-05	CcSEcCtD
Tacrolimus—Body temperature increased—Lisinopril—coronary artery disease	2.07e-05	9.85e-05	CcSEcCtD
Tacrolimus—Abdominal pain—Lisinopril—coronary artery disease	2.07e-05	9.85e-05	CcSEcCtD
Tacrolimus—Pruritus—Ramipril—coronary artery disease	2.05e-05	9.72e-05	CcSEcCtD
Tacrolimus—Asthenia—Timolol—coronary artery disease	2.03e-05	9.63e-05	CcSEcCtD
Tacrolimus—Nausea—Losartan—coronary artery disease	2e-05	9.51e-05	CcSEcCtD
Tacrolimus—Pruritus—Timolol—coronary artery disease	2e-05	9.5e-05	CcSEcCtD
Tacrolimus—Diarrhoea—Ramipril—coronary artery disease	1.98e-05	9.4e-05	CcSEcCtD
Tacrolimus—Diarrhoea—Timolol—coronary artery disease	1.93e-05	9.19e-05	CcSEcCtD
Tacrolimus—Hypersensitivity—Lisinopril—coronary artery disease	1.93e-05	9.18e-05	CcSEcCtD
Tacrolimus—Dizziness—Ramipril—coronary artery disease	1.91e-05	9.08e-05	CcSEcCtD
Tacrolimus—Asthenia—Lisinopril—coronary artery disease	1.88e-05	8.94e-05	CcSEcCtD
Tacrolimus—Dizziness—Timolol—coronary artery disease	1.87e-05	8.88e-05	CcSEcCtD
Tacrolimus—Pruritus—Lisinopril—coronary artery disease	1.86e-05	8.81e-05	CcSEcCtD
Tacrolimus—Vomiting—Ramipril—coronary artery disease	1.84e-05	8.73e-05	CcSEcCtD
Tacrolimus—Rash—Ramipril—coronary artery disease	1.82e-05	8.66e-05	CcSEcCtD
Tacrolimus—Dermatitis—Ramipril—coronary artery disease	1.82e-05	8.65e-05	CcSEcCtD
Tacrolimus—Headache—Ramipril—coronary artery disease	1.81e-05	8.6e-05	CcSEcCtD
Tacrolimus—Vomiting—Timolol—coronary artery disease	1.8e-05	8.54e-05	CcSEcCtD
Tacrolimus—Diarrhoea—Lisinopril—coronary artery disease	1.79e-05	8.52e-05	CcSEcCtD
Tacrolimus—Rash—Timolol—coronary artery disease	1.78e-05	8.47e-05	CcSEcCtD
Tacrolimus—Dermatitis—Timolol—coronary artery disease	1.78e-05	8.46e-05	CcSEcCtD
Tacrolimus—Headache—Timolol—coronary artery disease	1.77e-05	8.41e-05	CcSEcCtD
Tacrolimus—Dizziness—Lisinopril—coronary artery disease	1.73e-05	8.24e-05	CcSEcCtD
Tacrolimus—Nausea—Ramipril—coronary artery disease	1.72e-05	8.16e-05	CcSEcCtD
Tacrolimus—Nausea—Timolol—coronary artery disease	1.68e-05	7.97e-05	CcSEcCtD
Tacrolimus—Vomiting—Lisinopril—coronary artery disease	1.67e-05	7.92e-05	CcSEcCtD
Tacrolimus—Rash—Lisinopril—coronary artery disease	1.65e-05	7.85e-05	CcSEcCtD
Tacrolimus—Dermatitis—Lisinopril—coronary artery disease	1.65e-05	7.85e-05	CcSEcCtD
Tacrolimus—Headache—Lisinopril—coronary artery disease	1.64e-05	7.8e-05	CcSEcCtD
Tacrolimus—Nausea—Lisinopril—coronary artery disease	1.56e-05	7.4e-05	CcSEcCtD
Tacrolimus—ABCB1—Metabolism—DCN—coronary artery disease	3.44e-06	2.72e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PPP2CA—coronary artery disease	3.43e-06	2.71e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—JAK2—coronary artery disease	3.42e-06	2.71e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—JAK2—coronary artery disease	3.37e-06	2.67e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ABCA1—coronary artery disease	3.36e-06	2.66e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PSMA6—coronary artery disease	3.36e-06	2.65e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PSMB5—coronary artery disease	3.36e-06	2.65e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ALDH2—coronary artery disease	3.35e-06	2.65e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—AKR1B1—coronary artery disease	3.34e-06	2.64e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—HK2—coronary artery disease	3.34e-06	2.64e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—HIF1A—coronary artery disease	3.32e-06	2.63e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—AGT—coronary artery disease	3.31e-06	2.62e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—MTHFR—coronary artery disease	3.29e-06	2.6e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CTGF—coronary artery disease	3.28e-06	2.59e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—HBA1—coronary artery disease	3.26e-06	2.58e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—LIPC—coronary artery disease	3.26e-06	2.58e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CYP2C19—coronary artery disease	3.26e-06	2.58e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PIK3C2A—coronary artery disease	3.26e-06	2.58e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GGT1—coronary artery disease	3.26e-06	2.58e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GOT1—coronary artery disease	3.26e-06	2.58e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—HMGCR—coronary artery disease	3.25e-06	2.57e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GOT2—coronary artery disease	3.25e-06	2.57e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—APOC3—coronary artery disease	3.24e-06	2.57e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—LEP—coronary artery disease	3.24e-06	2.56e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—APOE—coronary artery disease	3.24e-06	2.56e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—LDLR—coronary artery disease	3.22e-06	2.55e-05	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—IL6—coronary artery disease	3.21e-06	2.54e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—APOA1—coronary artery disease	3.21e-06	2.53e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—SLC27A1—coronary artery disease	3.2e-06	2.53e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL1B—coronary artery disease	3.2e-06	2.53e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GSTT1—coronary artery disease	3.19e-06	2.52e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—SLC9A1—coronary artery disease	3.19e-06	2.52e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—KDR—coronary artery disease	3.18e-06	2.51e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—PTGS2—coronary artery disease	3.17e-06	2.51e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MAPK14—coronary artery disease	3.16e-06	2.5e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CETP—coronary artery disease	3.15e-06	2.49e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GCLC—coronary artery disease	3.15e-06	2.49e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—LCAT—coronary artery disease	3.14e-06	2.48e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CPT1B—coronary artery disease	3.14e-06	2.48e-05	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—AKT1—coronary artery disease	3.14e-06	2.48e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—PIK3CA—coronary artery disease	3.14e-06	2.48e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—AGT—coronary artery disease	3.12e-06	2.47e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—SDC1—coronary artery disease	3.11e-06	2.46e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—VEGFA—coronary artery disease	3.11e-06	2.46e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—ESR1—coronary artery disease	3.1e-06	2.45e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	3.09e-06	2.44e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—APOA4—coronary artery disease	3.08e-06	2.44e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—IL6—coronary artery disease	3.07e-06	2.43e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—APOE—coronary artery disease	3.06e-06	2.42e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—FN1—coronary artery disease	3.06e-06	2.42e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—F2—coronary artery disease	3.06e-06	2.42e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL6ST—coronary artery disease	3.05e-06	2.41e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—APOA1—coronary artery disease	3.03e-06	2.39e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NFKBIA—coronary artery disease	3.02e-06	2.39e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PLCB1—coronary artery disease	2.99e-06	2.36e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PDHA1—coronary artery disease	2.98e-06	2.35e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GCLM—coronary artery disease	2.98e-06	2.35e-05	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—AKT1—coronary artery disease	2.97e-06	2.35e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PSMB5—coronary artery disease	2.94e-06	2.33e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PSMA6—coronary artery disease	2.94e-06	2.33e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	2.93e-06	2.32e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—KIT—coronary artery disease	2.93e-06	2.31e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GSTP1—coronary artery disease	2.93e-06	2.31e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PPARGC1A—coronary artery disease	2.9e-06	2.29e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—ABCA1—coronary artery disease	2.9e-06	2.29e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—HMOX1—coronary artery disease	2.89e-06	2.28e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—TXNRD1—coronary artery disease	2.88e-06	2.28e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CYP11B2—coronary artery disease	2.88e-06	2.28e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CTGF—coronary artery disease	2.87e-06	2.27e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TGFB1—coronary artery disease	2.86e-06	2.26e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—HMGCR—coronary artery disease	2.85e-06	2.25e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GOT2—coronary artery disease	2.85e-06	2.25e-05	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—AKT1—coronary artery disease	2.85e-06	2.25e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CAT—coronary artery disease	2.85e-06	2.25e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—SLC22A3—coronary artery disease	2.84e-06	2.25e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—AKT1—coronary artery disease	2.84e-06	2.24e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—GSK3B—coronary artery disease	2.81e-06	2.22e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GOT1—coronary artery disease	2.81e-06	2.22e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GGT1—coronary artery disease	2.81e-06	2.22e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—MAPK1—coronary artery disease	2.8e-06	2.22e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ARNTL—coronary artery disease	2.8e-06	2.21e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—HADH—coronary artery disease	2.8e-06	2.21e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	2.79e-06	2.21e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—POMC—coronary artery disease	2.79e-06	2.2e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CREB1—coronary artery disease	2.79e-06	2.2e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IL6—coronary artery disease	2.78e-06	2.2e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—APOB—coronary artery disease	2.76e-06	2.19e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CCL2—coronary artery disease	2.73e-06	2.16e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL6R—coronary artery disease	2.72e-06	2.15e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GSTM1—coronary artery disease	2.69e-06	2.13e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IGF1—coronary artery disease	2.68e-06	2.12e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PPARG—coronary artery disease	2.67e-06	2.11e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—APOA2—coronary artery disease	2.65e-06	2.1e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	2.65e-06	2.1e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GPX2—coronary artery disease	2.65e-06	2.1e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—LPL—coronary artery disease	2.64e-06	2.09e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—POMC—coronary artery disease	2.63e-06	2.08e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ABCG5—coronary artery disease	2.62e-06	2.07e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—SULT1A1—coronary artery disease	2.62e-06	2.07e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GPX4—coronary artery disease	2.62e-06	2.07e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—HK1—coronary artery disease	2.62e-06	2.07e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PLCB1—coronary artery disease	2.62e-06	2.07e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—HADHA—coronary artery disease	2.59e-06	2.05e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GPX1—coronary artery disease	2.58e-06	2.04e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—AKT1—coronary artery disease	2.56e-06	2.03e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GSTA1—coronary artery disease	2.56e-06	2.02e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—SERPINE1—coronary artery disease	2.54e-06	2.01e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ABCA1—coronary artery disease	2.54e-06	2.01e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—VEGFA—coronary artery disease	2.54e-06	2.01e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—LPA—coronary artery disease	2.53e-06	2e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GSTP1—coronary artery disease	2.52e-06	1.99e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CD36—coronary artery disease	2.51e-06	1.98e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PPARGC1A—coronary artery disease	2.5e-06	1.97e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—HMOX1—coronary artery disease	2.49e-06	1.97e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PPP2CA—coronary artery disease	2.48e-06	1.96e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—FGF2—coronary artery disease	2.46e-06	1.95e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GGT1—coronary artery disease	2.46e-06	1.94e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GOT1—coronary artery disease	2.46e-06	1.94e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CAT—coronary artery disease	2.45e-06	1.94e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PLCB3—coronary artery disease	2.45e-06	1.94e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—MAPK1—coronary artery disease	2.44e-06	1.93e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—PIK3CA—coronary artery disease	2.43e-06	1.92e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NOS3—coronary artery disease	2.43e-06	1.92e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—APOA5—coronary artery disease	2.43e-06	1.92e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—ALB—coronary artery disease	2.4e-06	1.9e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—APOB—coronary artery disease	2.38e-06	1.88e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—P4HB—coronary artery disease	2.38e-06	1.88e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—MTHFR—coronary artery disease	2.38e-06	1.88e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—JAK2—coronary artery disease	2.36e-06	1.87e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	2.34e-06	1.85e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—TGFB1—coronary artery disease	2.33e-06	1.84e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GSTM1—coronary artery disease	2.32e-06	1.83e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—TGFB1—coronary artery disease	2.29e-06	1.81e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—NOS3—coronary artery disease	2.29e-06	1.81e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—MAPK1—coronary artery disease	2.28e-06	1.81e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—LPL—coronary artery disease	2.27e-06	1.8e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—AGT—coronary artery disease	2.26e-06	1.79e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—MAPK1—coronary artery disease	2.25e-06	1.78e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GPX1—coronary artery disease	2.22e-06	1.75e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—APOE—coronary artery disease	2.21e-06	1.75e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GSTP1—coronary artery disease	2.21e-06	1.75e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—VCAN—coronary artery disease	2.2e-06	1.74e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PPARGC1A—coronary artery disease	2.19e-06	1.73e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—APOA1—coronary artery disease	2.19e-06	1.73e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ALDOA—coronary artery disease	2.19e-06	1.73e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—HMOX1—coronary artery disease	2.18e-06	1.72e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CD36—coronary artery disease	2.16e-06	1.71e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CXCL8—coronary artery disease	2.16e-06	1.7e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IL6—coronary artery disease	2.15e-06	1.7e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CAT—coronary artery disease	2.15e-06	1.7e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PPP2CA—coronary artery disease	2.13e-06	1.69e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—DCN—coronary artery disease	2.12e-06	1.68e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—PIK3CA—coronary artery disease	2.11e-06	1.67e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PTGS2—coronary artery disease	2.1e-06	1.66e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—APOB—coronary artery disease	2.09e-06	1.65e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ALDH2—coronary artery disease	2.06e-06	1.63e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CASP3—coronary artery disease	2.06e-06	1.63e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—MTHFR—coronary artery disease	2.05e-06	1.62e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GSTM1—coronary artery disease	2.03e-06	1.6e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—HBA1—coronary artery disease	2.01e-06	1.59e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	2.01e-06	1.59e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—LIPC—coronary artery disease	2.01e-06	1.59e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CYP2C19—coronary artery disease	2.01e-06	1.59e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CCND1—coronary artery disease	2.01e-06	1.59e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—APOC3—coronary artery disease	2e-06	1.58e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—LPL—coronary artery disease	1.99e-06	1.58e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—LDLR—coronary artery disease	1.99e-06	1.57e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—AKT1—coronary artery disease	1.99e-06	1.57e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—PIK3CA—coronary artery disease	1.98e-06	1.57e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—SLC9A1—coronary artery disease	1.96e-06	1.55e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GSTT1—coronary artery disease	1.96e-06	1.55e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—PIK3CA—coronary artery disease	1.95e-06	1.54e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MMP9—coronary artery disease	1.95e-06	1.54e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—AGT—coronary artery disease	1.94e-06	1.54e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GPX1—coronary artery disease	1.94e-06	1.54e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GCLC—coronary artery disease	1.94e-06	1.53e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CETP—coronary artery disease	1.94e-06	1.53e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PPARG—coronary artery disease	1.93e-06	1.52e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—SDC1—coronary artery disease	1.92e-06	1.52e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—APOE—coronary artery disease	1.91e-06	1.51e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—POMC—coronary artery disease	1.9e-06	1.5e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CD36—coronary artery disease	1.89e-06	1.5e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—APOA1—coronary artery disease	1.88e-06	1.49e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL6—coronary artery disease	1.87e-06	1.48e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PPP2CA—coronary artery disease	1.87e-06	1.48e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PSMA6—coronary artery disease	1.81e-06	1.43e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PSMB5—coronary artery disease	1.81e-06	1.43e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.8e-06	1.43e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—MTHFR—coronary artery disease	1.79e-06	1.42e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CTGF—coronary artery disease	1.77e-06	1.4e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.75e-06	1.39e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GOT2—coronary artery disease	1.75e-06	1.39e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—VEGFA—coronary artery disease	1.75e-06	1.38e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ALB—coronary artery disease	1.73e-06	1.37e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—IL6—coronary artery disease	1.73e-06	1.37e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—AKT1—coronary artery disease	1.73e-06	1.37e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—AGT—coronary artery disease	1.7e-06	1.35e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—APOE—coronary artery disease	1.67e-06	1.32e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PPARG—coronary artery disease	1.66e-06	1.31e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—NOS3—coronary artery disease	1.66e-06	1.31e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—APOA1—coronary artery disease	1.65e-06	1.31e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—POMC—coronary artery disease	1.64e-06	1.29e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—AKT1—coronary artery disease	1.62e-06	1.28e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.61e-06	1.28e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TGFB1—coronary artery disease	1.61e-06	1.27e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—AKT1—coronary artery disease	1.59e-06	1.26e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MAPK1—coronary artery disease	1.58e-06	1.25e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.56e-06	1.24e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PTGS2—coronary artery disease	1.52e-06	1.2e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GGT1—coronary artery disease	1.51e-06	1.2e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GOT1—coronary artery disease	1.51e-06	1.2e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PPARG—coronary artery disease	1.45e-06	1.15e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—POMC—coronary artery disease	1.43e-06	1.13e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—NOS3—coronary artery disease	1.43e-06	1.13e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PIK3CA—coronary artery disease	1.37e-06	1.08e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.36e-06	1.08e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.35e-06	1.07e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.34e-06	1.06e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CAT—coronary artery disease	1.32e-06	1.05e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ALB—coronary artery disease	1.31e-06	1.03e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PTGS2—coronary artery disease	1.31e-06	1.03e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PIK3CA—coronary artery disease	1.29e-06	1.02e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—APOB—coronary artery disease	1.29e-06	1.02e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—NOS3—coronary artery disease	1.25e-06	9.89e-06	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.25e-06	9.89e-06	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—LPL—coronary artery disease	1.23e-06	9.7e-06	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL6—coronary artery disease	1.21e-06	9.57e-06	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GPX1—coronary artery disease	1.2e-06	9.47e-06	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CD36—coronary artery disease	1.17e-06	9.22e-06	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.15e-06	9.1e-06	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PTGS2—coronary artery disease	1.14e-06	9.05e-06	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—AKT1—coronary artery disease	1.12e-06	8.83e-06	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.11e-06	8.74e-06	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—AKT1—coronary artery disease	1.05e-06	8.34e-06	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—AGT—coronary artery disease	1.05e-06	8.3e-06	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—APOE—coronary artery disease	1.03e-06	8.13e-06	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—APOA1—coronary artery disease	1.02e-06	8.04e-06	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PIK3CA—coronary artery disease	9.33e-07	7.38e-06	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PPARG—coronary artery disease	8.96e-07	7.09e-06	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—POMC—coronary artery disease	8.84e-07	6.99e-06	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ALB—coronary artery disease	8.06e-07	6.37e-06	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PIK3CA—coronary artery disease	8.03e-07	6.35e-06	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—NOS3—coronary artery disease	7.71e-07	6.09e-06	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—AKT1—coronary artery disease	7.62e-07	6.03e-06	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PTGS2—coronary artery disease	7.05e-07	5.57e-06	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PIK3CA—coronary artery disease	7.04e-07	5.57e-06	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—AKT1—coronary artery disease	6.56e-07	5.19e-06	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—AKT1—coronary artery disease	5.75e-07	4.55e-06	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PIK3CA—coronary artery disease	4.34e-07	3.43e-06	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—AKT1—coronary artery disease	3.54e-07	2.8e-06	CbGpPWpGaD
